{
    "Trade/Device Name(s)": [
        "Complete D 25-OH Vitamin D Control",
        "Quantimetrix Complete D 25-OH Vitamin D Control"
    ],
    "Submitter Information": "Quantimetrix Corporation",
    "510(k) Number": "K113177",
    "Predicate Device Reference 510(k) Number(s)": [
        "K110641"
    ],
    "Regulatory Class": "Class I, reserved",
    "Product Code(s)": [
        "JJX"
    ],
    "Summary Letter Date": "April 19, 2012",
    "Summary Letter Received Date": "April 23, 2012",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR862.1660"
    ],
    "Regulation Name(s)": [
        "Quality control material (assayed and unassayed)"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "25-OH Vitamin D",
        "Total 25-OH Vitamin D",
        "25-Hydroxyvitamin D"
    ],
    "Specimen Type(s)": [
        "Human serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "Control",
        "Quality control material"
    ],
    "Document Summary": "FDA 510(k) summary for Quantimetrix Complete D 25-OH Vitamin D Control as a quality control material for laboratory measurement of total 25-OH vitamin D.",
    "Indications for Use Summary": "Intended for the quality control of laboratory procedures used to quantitate total 25-OH Vitamin D.",
    "fda_folder": "Clinical Chemistry"
}